Pathogenetic treatment for neurotrophic keratopathy 
T. B. Gaidamaka, Dr. Sc. (Med.); T. A. Veliksar, Postgraduate Student; G. I. Drozhzhyna, Dr. Sc. (Med.); T. M. Serebrina, Cand. Sc. (Med.) 
Filatov Institute of Eye Diseases and Tissue Therapy; 
Odessa (Ukraine)
Introduction. Continuous soft contact lens (SCL) wearing can result in development of neurotrophic keratopathy. Treatment of this pathology is long-term and, in general, symptomatic: tear-substitute, epithelizing, vitaminous, antibacterial, anti-inflammatory therapy.
Purpose. To improve a correction method for metabolic alterations in corneal tissues in continuous-SCL-wear-associated neurotrophic keratopathy through using transorbital electrophoresis with 1% thiotriazoline.  
Material and Methods. We developed a method of treatment for neurotrophic keratopathy which includes a 10 day course of daily transorbital electrophoresis with 1% thiotriazoline as a part of complex therapy. We applied for approval of Author's certificate (application No U 201710621 dated 01 November 2017).
Results. Clinical cases of treatment of stage 1 neurotrophic keratopathy are reported.   
Conclusion. The proposed treatment enables in a short term to significantly decrease pathological changes in corneal tissues in stage 1 neurotrophic keratopathy, to increase comfort in the eyes, to prevent severe complications of neurotrophic keratopathy and soft contact lens wearing. 
Key-words: neurotrophic keratopathy, contact lenses, thiotriazoline, electrophoresis
  1. Efron N. Staining of the cornea caused by contact lens wear. Glaz. 2000;1(11): 5-13. Russian. 
  2. Drozhzhina GI, Ivanova ON, Gaidamaka TB. et al. Severe corneal infections induced by contact lens wearing. J.ophthalmol.(Ukraine).2016;6:38-42. 
  3. Cavanagh HD, Petroll M, Alizadeh H et al. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology.  1993;100(10):1444 – 53.
  4. Dart JK,  Radford CF,  Minassian D,  Verma S,  Stapleton F. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology.2008;115(10):1647-54. 
  5. Ziadi M,  Moiroux P,  d'Athis P et al. Assessment of induced corneal hypoxia in diabetic patients. 2002;21(5):453-7.
  6. Gaidamaka T, Veliksar T, Drozhzhyna G, Hramenko N. [Condition of tear film, conjunctiva, limbus and cornea in long-term use of siliconehydrogel contact lenses]. Oftalmologiia. Vostochnaia Evropa. 7(3): 289-98. Russian.
  7. Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin. Ophthalmol. 2014;8:571−9.
  8. Trofimova TS, Briuzgina TS, Chekman IS. [Effect of thiotriazolinum on lipid indices in the liver and the heart of rats in toxic action of doxorubicin]. Zaporozh. med. zhurn. 2005;1:124-6. Ukrainian.  
  9. Cherikchi LE. [Physiotherapy in ophthalmology]. Kyiv: Zdorovya;1979:3-4;53-4. Russian.  
  10. Chekman IS, Replianchuk ND. [Use of thiotriazolinum  and corneregel in pharmacotherapy of dystrophic diseases of the anterior eye]. [Proceedings of scientific practical conference “Filatov Memorial Lectures – 2013”: 52-3. Ukrainian.